Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001628280-23-008825

Chief Executive Officer acquired 168,512 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hively Brad Chief Executive Officer 2023-03-17 Grant or award +168,512 724,182 D
Derivatives
Hively Brad Chief Executive Officer 2023-03-17 Grant or award · Non-Qualified Stock Option (right to buy) +421,280 421,280 D
Loading xslF345X04/wf-form4_167944585635107.xml…